KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on SalesTimes Interest Earned

Gsk (GSK) Return on Sales (2016 - 2026)

Gsk has reported Return on Sales over the past 18 years, most recently at 0.0% for Q1 2026.

  • For Q1 2026, Return on Sales changed 0.0% year-over-year to 0.0%; the TTM value through Mar 2026 reached 0.0%, changed 0.0%, while the annual FY2025 figure was 0.0%, N/A changed from the prior year.
  • Return on Sales for Q1 2026 was 0.0% at Gsk, up from 0.0% in the prior quarter.
  • Over five years, Return on Sales peaked at 0.01% in Q3 2022 and troughed at 0.0% in Q3 2024.
  • A 5-year average of 0.0% and a median of 0.0% in 2023 define the central range for Return on Sales.
  • Biggest five-year swings in Return on Sales: grew 1bps in 2022 and later fell -1bps in 2023.
  • Year by year, Return on Sales stood at 0.0% in 2022, then surged by 523bps to 0.0% in 2023, then plummeted by -32bps to 0.0% in 2024, then tumbled by -41bps to 0.0% in 2025, then surged by 155bps to 0.0% in 2026.
  • Business Quant data shows Return on Sales for GSK at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.